IL-2 Immunotoxin Therapy Modulates Tumor-Associated Regulatory T Cells and Leads to Lasting Immune-Mediated Rejection of Breast Cancers in neu-Transgenic Mice-Reference-Cited by-同舟云学术

IL-2 Immunotoxin Therapy Modulates Tumor-Associated Regulatory T Cells and Leads to Lasting Immune-Mediated Rejection of Breast Cancers in neu-Transgenic Mice

Published:2006-06-19 Issue:1 Volume:177 Page:84-91
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Knutson Keith L.,Dang Yushe,Lu Hailing,Lukas Jason,Almand Bond,Gad Ekram,Azeke Ehizoje,Disis Mary L.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference50 articles.

1. Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer

2. T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role.

3. Prognostic significance of T-cell infiltrates, expression of β2-microglobulin and HLA-DR antigens in breast carcinoma

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Introduction of a new recombinant vaccine based on GRP78 for breast cancer immunotherapy and evaluation in a mouse model;BioImpacts;2023-09-18

2. Therapeutic targeting of regulatory T cells in cancer;Trends in Cancer;2022-11

3. Decrease of Tumor-infiltrating Regulatory T Cells using Pentoxifylline: An Ex Vivo Analysis in Triple-negative Breast Cancer Mouse Model;Iranian Journal of Allergy, Asthma and Immunology;2022-04-17

4. Regulatory T cells: Their role in triple‐negative breast cancer progression and metastasis;Cancer;2022-01-06

5. Role of regulatory T cells in cancer;Role of Tumor Microenvironment in Breast Cancer and Targeted Therapies;2022